D M French|W C Brown|G H Palmer - JoVE Visualize

Showing results (1-10 of 262) with videos related to

Pageof 27

Sort By:

Infection and Immunity|October 26, 1999

Emergence of Anaplasma marginale antigenic variants during persistent rickettsemiaD M French, W C Brown, G H Palmer

Parasitology Today (Personal Ed.)|June 23, 1999

Designing blood-stage vaccines against Babesia bovis and B. bigeminaW C Brown, G H Palmer

Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000

Identification of fetal liver tyrosine kinase 3 (flt3) ligand domain required for receptor binding and function using naturally occurring ligand isoformsW Mwangi, W C Brown, G H Palmer

Microbes and Infection|April 1, 2000

Antigenic variation in the persistence and transmission of the ehrlichia Anaplasma marginaleG H Palmer, W C Brown, F R Rurangirwa

Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999

Restriction of major surface protein 2 (MSP2) variants during tick transmission of the ehrlichia Anaplasma marginaleF R Rurangirwa, D Stiller, D M French, et al.

Infection and Immunity|November 24, 1998

Persistence of Anaplasma ovis infection and conservation of the msp-2 and msp-3 multigene families within the genus AnaplasmaG H Palmer, J R Abbott, D M French, et al.

Infection and Immunity|March 6, 1998

Expression of Anaplasma marginale major surface protein 2 variants during persistent cyclic rickettsemiaD M French, T F McElwain, T C McGuire, et al.

Infection and Immunity|October 13, 2001

CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strainsW C Brown, G H Palmer, H A Lewin, et al.

Parasitology Today (Personal Ed.)|June 23, 1999

Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginaleG H Palmer, F R Rurangirwa, K M Kocan, et al.

Infection and Immunity|December 22, 1999

Interleukin-12 as an adjuvant promotes immunoglobulin G and type 1 cytokine recall responses to major surface protein 2 of the ehrlichial pathogen Anaplasma marginaleW Tuo, G H Palmer, T C McGuire, et al.

Pageof 27

Showing results (1-10 of 262) with videos related to

Sort By:

Pageof 27

Infection and Immunity|October 26, 1999

Emergence of Anaplasma marginale antigenic variants during persistent rickettsemiaD M French, W C Brown, G H Palmer

Parasitology Today (Personal Ed.)|June 23, 1999

Designing blood-stage vaccines against Babesia bovis and B. bigeminaW C Brown, G H Palmer

Journal of Immunology (Baltimore, Md. : 1950)|December 20, 2000

Identification of fetal liver tyrosine kinase 3 (flt3) ligand domain required for receptor binding and function using naturally occurring ligand isoformsW Mwangi, W C Brown, G H Palmer

Microbes and Infection|April 1, 2000

Antigenic variation in the persistence and transmission of the ehrlichia Anaplasma marginaleG H Palmer, W C Brown, F R Rurangirwa

Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999

Restriction of major surface protein 2 (MSP2) variants during tick transmission of the ehrlichia Anaplasma marginaleF R Rurangirwa, D Stiller, D M French, et al.

Infection and Immunity|November 24, 1998

Persistence of Anaplasma ovis infection and conservation of the msp-2 and msp-3 multigene families within the genus AnaplasmaG H Palmer, J R Abbott, D M French, et al.

Infection and Immunity|March 6, 1998

Expression of Anaplasma marginale major surface protein 2 variants during persistent cyclic rickettsemiaD M French, T F McElwain, T C McGuire, et al.

Infection and Immunity|October 13, 2001

CD4(+) T lymphocytes from calves immunized with Anaplasma marginale major surface protein 1 (MSP1), a heteromeric complex of MSP1a and MSP1b, preferentially recognize the MSP1a carboxyl terminus that is conserved among strainsW C Brown, G H Palmer, H A Lewin, et al.

Parasitology Today (Personal Ed.)|June 23, 1999

Molecular basis for vaccine development against the ehrlichial pathogen Anaplasma marginaleG H Palmer, F R Rurangirwa, K M Kocan, et al.

Infection and Immunity|December 22, 1999

Interleukin-12 as an adjuvant promotes immunoglobulin G and type 1 cytokine recall responses to major surface protein 2 of the ehrlichial pathogen Anaplasma marginaleW Tuo, G H Palmer, T C McGuire, et al.

Pageof 27